Abstract:BACKGROUND AND OBJECTIVEMultiple drug resistance (MDR) to chemotherapeutic agents often leads to a failure to respond to chemotherapy. We utilized an in vitro chemosensitivity test to identify sensitive and effective chemotherapeutic drugs and further elucidated the correlation between the in vivo chemosensitivity and clinical outcomes.METHODSHere, we evaluated the in vitro chemosensitivity and MDR of 120 lung cancer patients to eight singledrug chemotherapies and of 291 lung cancer patients to seven chemotherapy regimens using an ATP-based tumor chemosensitivity assay (ATP-TCA). Additionally, the chemosensitivity profiles of lung adenocarcinoma patients (284 cases) and lung squamous cell carcinoma patients (90 cases) to these single-drug and chemotherapy regimens were compared. Furthermore, the correlations between the chemosensitivity and clinical outcomes were investigated in 16 stage III squamous cell carcinoma patients.RESULTS AND CONCLUSIONPTX (51.7%), TXT (43.3%), GEM (12.5%), PTX+DDP (62.5%), TXT+L-OHP (54.3%) and VP-16+DDP (16.2%) had the highest in vitro chemosensitivity rates. Approximately 31.7% of patients developed resistance to all eight single-drug chemotherapies, and 25.8% of patients displayed resistance to all seven chemotherapy regimens. In addition, lung squamous cell carcinoma was significantly more sensitive to GEM and MTA+DDP than lung adenocarcinoma (P<0.05). Further analysis showed that patients with higher drug sensitivity tended to have longer disease-free survival (18 months vs. 8.5 months) than patients displaying drug resistance (P<0.05). These results suggest that the implementation of in vitro drug susceptibility testing before chemotherapy can effectively prevent the occurrence of primary drug resistance and inappropriate drug treatment.

Investigation On The Sensitivities Of Single And Combined Antitumor Drugs In Vitro By Real-Time Cell Electronic Sensing Technology

DYNAMIC INVESTIGATION IN VITRO ON THE SENSITIVITY OF SMMC-7721 CELL TO SINGLE ANTITUMOR DRUGS

Application Research of the Microelectronic Cell Sensor in Drug Analysis of Anti-Cancer

Analysis of Cytotoxic Effects of Chemotherapeutic Agents for Gastrointestinal Cancer with Cell-based Impedance Biosensor

Micro-electrode cell-based biosensor using electrochemical impedance spectroscopy for cancer research

Experiment on the Factors for Enhancing the Susceptibility of Cancer Cells to Chemotherapeutic Drug by Ultrasound Microbubbles.

Study on the chemosensitivity test with TECIA in vitro for the choice of individualized chemotherapy of lung cancer

In Vitro Anticancer Drug Sensitivity Sensing Through Single-Cell Raman Spectroscopy

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

Comparison of Cytotoxicity Evaluation of Anticancer Drugs between Real-Time Cell Analysis and CCK-8 Method

Chemosensitivity in vitro of 25 anti-cancer drugs to primary cultured human breast cancer cells

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Application of a Microfluidic Chip-Based 3D Co-Culture to Test Drug Sensitivity for Individualized Treatment of Lung Cancer.

Analysis of Drug Sensitivity and Its Guidance in Clinic in 61 Cases of Breast Cancer Cell

APOPTOSIS AND DRUG SENSITITY TEST OF LUNG CANCER CELL

Profiling Protein Markers Associated with the Sensitivity to Concurrent Chemoradiotherapy in Human Cervical Carcinoma.

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance

Composition for detecting chemoradiotherapy sensitivity of rectal cancers, micro array and computer system